Huang Y, Qin L, Guan S, Guang Y, Wei Y, Cao A, Li D, Wei G, Su Q
College of Health Science, Guangdong Pharmaceutical University, Guangzhou 510006, China.
School of Pharmaceutical Sciences, Sun Yatsen University, Guangzhou 510060, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jul 20;44(7):1336-1344. doi: 10.12122/j.issn.1673-4254.2024.07.13.
To explore the key targets and signaling pathways in the therapeutic mechanism of Chang (SC) root against pancreatic cancer network pharmacology and molecular docking studies and cell experiments.
The targets of SC and pancreatic cancer were predicted using the network pharmacological database, the protein-protein interaction network was constructed, and pathways, functional enrichment and molecular docking analyses were performed. CCK-8 assay was used to test the inhibitory effect of the aqueous extract of SC root on 8 cancer cell lines, and its effects on invasion, migration, proliferation, and apoptosis of pancreatic cancer cells were evaluated. Western blotting was performed to verify the results of network pharmacology analysis.
We identified a total of 18 active components in SC, which regulated 21 potential key targets in pancreatic cancer. GO and KEGG pathway enrichment analyses showed that these targets were involved mainly in the biological processes including protein phosphorylation, signal transduction, and apoptosis and participated in cancer signaling and PI3K-Akt signaling pathways. Among the 8 cancer cell lines, The aqueous extract of SC root produced the most obvious inhibitory effect in pancreatic cancer cells, and significantly inhibited the invasion, migration, and proliferation and promoted apoptosis of pancreatic cancer Panc-1 cells ( < 0.05). Western blotting confirmed that SC significantly inhibited the phosphorylation levels of PI3K and AKT in Panc-1 cells ( < 0.001).
The therapeutic effect of SC root against pancreatic cancer effects is mediated by its multiple components that act on different targets and pathways including the PI3K-Akt pathway.
通过网络药理学、分子对接研究及细胞实验,探索蟾酥治疗胰腺癌机制中的关键靶点和信号通路。
利用网络药理学数据库预测蟾酥和胰腺癌的靶点,构建蛋白质-蛋白质相互作用网络,并进行通路、功能富集和分子对接分析。采用CCK-8法检测蟾酥根水提取物对8种癌细胞系的抑制作用,评估其对胰腺癌细胞侵袭、迁移、增殖和凋亡的影响。通过蛋白质印迹法验证网络药理学分析结果。
共鉴定出蟾酥中的18种活性成分,这些成分调控胰腺癌中的21个潜在关键靶点。基因本体(GO)和京都基因与基因组百科全书(KEGG)通路富集分析表明,这些靶点主要参与蛋白质磷酸化、信号转导和凋亡等生物学过程,参与癌症信号通路和PI3K-Akt信号通路。在8种癌细胞系中,蟾酥根水提取物对胰腺癌细胞的抑制作用最明显,显著抑制胰腺癌细胞Panc-1的侵袭、迁移和增殖,并促进其凋亡(P<0.05)。蛋白质印迹法证实,蟾酥显著抑制Panc-1细胞中PI3K和AKT的磷酸化水平(P<0.001)。
蟾酥根对胰腺癌的治疗作用是由其多种成分介导的,这些成分作用于包括PI3K-Akt通路在内的不同靶点和信号通路。